Clinical Study for the Treatment of Cardiomyopathy
This is a clinical study to assess the similarity of 1x 15mg dose versus 3x 5mg dose of mavacamten for the treatment of cardiomyopathy. This study is to assess how a capsule is processed in the body when given different formulations of an FDA approved medication.
This study has two separate admits each of 4 nights and 5 days & 11 outpatient visits over 4 months.
up to $8,750
- Medication: Any prescription medications within 28 days or OTC medications within 14 days prior to dosing.
- Contraception: Willing to adhere to the contraception requirements for this study
- Smoking Status: Must not have used any tobacco products within 2 months prior to dose